Navigation Links
Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016
Date:2/7/2012

NEW YORK, Feb. 7, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016

http://www.reportlinker.com/p0769056/Indian-Diagnostic--Therapeutic-Antibodies-Market-Report--Forecast-2011-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Biopharmaceutical

Advancements in antibody technology has revolutionized both the diagnostic and therapeutic sciences. As of today, monoclonal antibodies can be produced virtually against any antigen and they have transformed the diagnostic industry in view of their specificity towards specific antigens and almost unlimited production capabilities. In the field of therapeutics, they have changed the treatment possibilities and significantly improved the life expectancies of patients who were earlier having very high unmet needs.

IMARC Group, one of the world's leading research and advisory firms, in its latest report "Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016" finds that the Indian market for both therapeutic and diagnostic antibodies is expected to grow exponentially in the coming years. Findings from the report suggest that more than 60% of the total antibodies market is currently dominated by diagnostic antibodies. This segment, however, is more mature, has lower entry barriers and is extremely price sensitive. The market for therapeutic antibodies in India, on the other hand, is still in its infancy and more than half of the globally launched therapeutic monoclonal antibodies are currently not even available here. In the coming years, however, we expect this market to explode. Driven by a continuous increase in healthcare expenditures, increasing affordability, and a number of new product launches, we expect the market for therapeutic antibodies to grow at a CAGR of 27% in the next five years.

IMARC's new report entitled "Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016" provides an analytical and statistical insight into the Indian Antibodies market. The study, that has been undertaken using desk-based as well as qualitative primary research, provides and draws upon analysis of the following aspects of the Indian antibodies market.

Key Aspects Analyzed: Diagnostic Antibodies

Understanding the strengths, weaknesses, opportunities and challenges in the Indian diagnostic antibodies market

Understanding the technological considerations and regulatory factors in the Indian diagnostic antibodies market

• Evaluating the various types of antibody based diagnostic tests conducted in India and analyzing their strengths and weaknesses• Understanding the key regulations for registering, manufacturing and importing diagnostics in India

Comprehensive situation analysis of the Indian diagnostic antibodies market

Segments covered: HIV, Hepatitis B, Hepatitis C, Tuberculosis, Dengue, Syphilis and Oncology

Focus of the analysis in each segment:

• Number of tests conducted each year

• Breakup by type of tests conducted

• Current and future market sales

• Average cost of diagnostic tests

• Key players operating in the market

Therapeutic Antibodies Understanding the strengths, weaknesses, opportunities and challenges in the Indian therapeutic antibodies market

Understanding the technological considerations and regulatory factors in the Indian therapeutic antibodies market• Evaluation and identification of monoclonal antibodies based on the sources from which they are derived and on the targets against which they act.• Understanding the key regulations for registering, manufacturing and importing therapeutic antibodies in India.

Evaluating the patent details of all globally marketed monoclonal antibodies in India, US and Europe

• Identifying the patentee name and patent numbers of all in-market monoclonal antibodies in India, US and Europe

• Identifying the monoclonal antibodies that are patent protected in India, US and Europe and those that are not

• Estimating the patent expiries of various monoclonal antibodies in India, US and Europe.

Comprehensive situation analysis of the Indian therapeutic antibodies market• Analyzing current and future sales of monoclonal antibodies in India• Identifying all globally launched monoclonal antibodies and understanding their performance and launch status in India• Analyzing the global and Indian monoclonal antibodies market by Indication• Evaluation of the top selling monoclonal antibodies• Key biosimilar antibody development programmes in India and abroad1 Market Definitions & Methodology2 Executive Summary3 Indian Antibodies Market4 Antibody Based Diagnostics Market in India4.1 Industry Analysis4.1.1 Strengths4.1.2 Weaknesses4.1.3 Opportunities4.1.4 Threats4.2 Technological & Regulatory Assessment4.2.1 Technological Assessment4.2.2 Regulatory Assessment4.3 Market Analysis4.3.1 Current & Future Sales Trends4.3.2 Market Segments by Usage4.3.2.1 HIV Diagnostics: Current Trends & Forecast4.3.2.2 Hepatitis B Diagnostics: Current Trends & Forecast4.3.2.3 Hepatitis C Diagnostics: Current Trends & Forecast4.3.2.4 Tuberculosis Diagnostics: Current Trends & Forecast4.3.2.5 Dengue Diagnostics: Current Trends & Forecast4.3.2.6 Pregnancy Diagnostics: Current Trends & Forecast4.3.2.7 Syphilis Diagnostics: Current Trends & Forecast4.3.2.8 Oncology Diagnostics: Current Trends & Forecast5 Therapeutic Antibodies Market in India5.1 Industry Analysis5.1.1 Strengths5.1.2 Weaknesses5.1.3 Opportunities5.1.4 Threats5.2 Technological & Regulatory Assessment5.2.1 Technological Assessment5.2.2 Regulatory Assessment5.3 Patent Details of Various Monoclonal Antibodies: US, Europe & India5.4 Market Analysis5.4.1 Current & Future Sales Trends5.4.2 Sales Breakup by Molecule5.4.3 Sales by Indication5.5 Evaluation of Top Monoclonal Antibodies5.5.1.1 Avastin5.5.1.2 Herceptin5.5.1.3 Rituxan/Mabthera5.5.1.4 Remicade5.5.1.5 Humira5.6 Biosimilar Case Studies5.6.1 Reditux5.6.2 Grafeel5.7 Key Indian & Foreign Biosimilar Antibody Development Programmes

List of Figures Figure 3 1: India - Antibodies Market Forecast, 2010-2016

Figure 3 2: India - Antibodies Market Forecast - Breakup by Segment (in %), 2010-2016

Figure 4 1: India - Overview of Elisa and Rapid Tests

Figure 4 2: India - In-Vitro Diagnostics Market Forecast (in INR Million), 2010-2016

Figure 4 3: India - Immunodiagnostics Market Forecast (in INR Million), 2010-2016

Figure 4 4: India - Immunodiagnostics Market Forecast: Breakup by Indication (in %), 2010 & 2016

Figure 4 5: India - HIV Diagnostics Market Forecast (in INR Million), 2010-2016

Figure 4 6: India - HIV Diagnostics Market: Volume Share by Lab (in %), 2010

Figure 4 7: India - HIV Diagnostics Market: Value & Volume Share of Various Tests (in %), 2010

Figure 4 8: India - Hepatitis B Diagnostics Market Forecast (in INR Million), 2010-2016

Figure 4 9: India - Hepatitis B Diagnostics Market: Share of Various Tests (in %), 2010

Figure 4 10: India - Hepatitis C Diagnostics Market Forecast (in INR Million), 2010-2016

Figure 4 11: India - Hepatitis C Diagnostics Market: Share of Various Tests (in %), 2010

Figure 4 12: India - Tuberculosis Diagnostics Market Forecast (in INR Million), 2010-2016

Figure 4 13: India - Tuberculosis Diagnostics Market: Share of Various Tests (in %), 2010

Figure 4 14: India - Dengue Diagnostics Market Forecast (in INR Million), 2010-2016

Figure 4 15: India - Dengue Diagnostics Market: Volume Share of Various Tests (in %), 2010

Figure 4 16: India - Pregnancy Market Forecast (in INR Million), 2010-2016

Figure 4 17: India - Syphilis Diagnostics Market Forecast (in INR Million), 2010-2016

Figure 4 18: India - Syphilis Diagnostics Market: Volume Share of Various Tests (in %), 2010

Figure 4 19: India - Cancer Diagnostics Market Forecast (in INR Million), 2010-2016

Figure 5 1: Monoclonal Antibodies Based on Their Sources

Figure 5 2: India - Approval Process for a New Drug

Figure 5 3: Global - Monoclonal Antibodies Market Forecast (in INR Million), 2010-2016

Figure 5 4: India - Monoclonal Antibodies Market Forecast (in INR Million), 2010-2016

Figure 5 5: Global - Monoclonal Antibodies Market: Sales Share by Molecule (in %), 2010

Figure 5 6: India - Monoclonal Antibodies Market: Sales Share by Molecule (in %), 2010

Figure 5 7: Global - Monoclonal Antibodies Market by Indication (in %), 2010

Figure 5 8: India - Monoclonal Antibodies Market by Indication (in %), 2010-2016

Figure 5 9: Global - Avastin Sales (in INR Million), 2006- 2010

Figure 5 10: Global - Avastin Sales Forecast (in INR Million), 2010-2016

Figure 5 11: Global - Herceptin Sales (in INR Million), 2006-2010

Figure 5 12: Global - Herceptin Sales Forecast (in INR Million), 2010-2016

Figure 5 13: Global - Rituxan/Mabthera Sales (in INR Million), 2006-2010

Figure 5 14: Global - Rituxan/Mabthera Sales Forecast (in INR Million), 2010-2016

Figure 5 15: Global - Remicade Sales (in INR Million), 2006-2010

Figure 5 16: Global - Remicade Sales Forecast (in INR Million), 2010-2016

Figure 5 17: Global - Humira Sales (in INR Million), 2006-2010

Figure 5 18: Global - Humira Sales Forecast (in INR Million), 2010-2016

Figure 5 19: India - Reditux Sales (in INR Million), 2007-08 - 2010-2011

Figure 5 20: India - Impact of Grafeel on G-CSF Market Size & Prices, 2000-01 - 2009-10

List of Tables Table 1 1: Monoclonal Antibodies Market: Market Definitions

Table 1 2: India - Immunodiagnostics Market: Market Definitions

Table 2 1: India - Diagnostic Antibodies Market - SWOT Analysis

Table 2 2: India - Executive Summary - Immunodiagnostics Market: Overview of Various Indications, 2010

Table 2 3: India - Therapeutic Antibodies Market - SWOT Analysis

Table 4 1: India - Statistics of Various Indications

Table 4 2: India - Comparison of Rapid & Elisa Tests

Table 4 3: India - Immunodiagnostics Market: Overview of Various Indications, 2010

Table 4 4: India - HIV Diagnostics Market: Key Statistics, 2010

Table 4 5: India - Hepatitis B Diagnostics Market: Key Statistics, 2010

Table 4 6: India - Hepatitis C Diagnostics Market: Key Statistics, 2010

Table 4 7: India - Tuberculosis Diagnostics Market: Key Statistics, 2010

Table 4 8: India - Cancer Diagnostics Market: Overview of Various Cancer Markers

Table 5 1: Globally Launched Monoclonal Antibodies & Their Targets

Table 5 2: US, Europe & India - Patent Details of Various Monoclonal Antibodies

Table 5 3: Global & Indian: Monoclonal Antibodies Market - Statistics of Various Brands

Table 5 4: India - Monoclonal Antibodies Market: Sales of Top Selling Molecules (in INR Million), 2010

Table 5 5: Drug Overview: Avastin

Table 5 6: Drug Overview: Herceptin

Table 5 7: Drug Overview: Rituxan

Table 5 8: Drug Overview: Remicade

Table 5 9: Drug Overview: Humira

Table 5 10: Drug Overview: Reditux

Table 5 11: Companies Developing Herceptin (Trastuzumab) Biosimilars

Table 5 12: Companies Developing Remicade (Infliximab) Biosimilars

Table 5 13: Companies Developing Mabthera (Rituximab) Biosimilars

Table 5 14: Companies Developing Humira (Trastuzumab) Biosimilars

Table 5 15: Companies Developing Other Monoclonal Antibody Biosimilars

To order this report:Biopharmaceutical Industry: Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016

More  

Market Research Report

Check our  

Industry Analysis and Insights

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
2. Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
3. Infinitus Clinical Research Consolidates- Sino-Indian CRO Enhances Core Capabilities
4. Reportlinker Adds Brazil, Russian, Indian and Chinese Markets for Endoscopic Devices 2009 (4 Countries)
5. Public Art to Complete Transformation of Key Gateway into Indianapolis
6. Indiana Blood Center Taps tw telecom for Data, Internet and IP Telephony Services
7. Kendle Receives Approval From Indian Government to Proceed With Development of Operations Center in Special Economic Zone
8. Infinitus Clinical Research Consolidates - Sino-Indian CRO Enhances Core Capabilities
9. Indian Glamour for This Summer
10. Total Federal Grant Funds for Indiana Health Information Technology Efforts Climb to Nearly $50 Million; Latest $16 Million Installment Spotlights Indiana Health Information Exchange in Delivering Higher Quality and Higher Value Healthcare Through M
11. Hill-Rom to Present at the INVESTIndiana Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... 24, 2016  Joe Marziani has joined VMS BioMarketing as senior vice president of ... In his new role, Marziani will lead the company,s business development and sales team, ... outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... -- Open Access Journal Focusing on ... Elsevier , a world-leading provider of scientific, technical ... launch of Clinical Neurophysiology Practice ... clinical practice issues in clinical neurophysiology. The journal will ... and didactic reviews. It is an official journal of ...
(Date:5/23/2016)... PUNE, India , May 23, 2016 ... is spread across 163 pages, profiles 12 companies and ... 280 tables and figures on the industry and its ... study that is comprehensive in nature, details the current ... of the industry including definitions, classifications, applications and industry ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... 24, 2016 , ... United Benefit Advisors (UBA), the nation’s ... Austin & Co., Inc. Headquartered in Albany, New York, Austin & Co., ... technology, and beyond. As an employee-owned company celebrating over 160 years of ...
(Date:5/24/2016)... ... May 24, 2016 , ... How to Write Error ... NC, http://www.fdanews.com/humanerrordrugdevice , Human error is known to be the major cause ... error will ever be totally eliminated, many human performance problems can be prevented. , ...
(Date:5/24/2016)... ... (PRWEB) May 24, 2016 -- ... of its Advisory Board. Joining the Grow Healthy Advisory Board ... of them embody the mission of our organization and bring talent, ... have them as we continue to expand our footprint as the ...
(Date:5/24/2016)... ... 2016 , ... Backed by decades of experience, Metroloji Okulu ... the best suited solution to meet regulatory requirements. Their professional staff also performs ... Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical ...
(Date:5/24/2016)... Mateo, CA (PRWEB) , ... May 24, 2016 ... ... dedicated to advancing the science and clinical practice of radiosurgery, is recognizing five ... of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). The awards will be ...
Breaking Medicine News(10 mins):